AI-Powered Drug Discovery Possibilities | Revvity Signals Software
Revvity Signals helps take advantage of AI-ready data within antibody drug discovery. Learn how Signals Research Suite can help accelerate scientific.
Search Results
R&D Reimagined: AI’s Role in Turning ‘What Ifs’ into ‘Why Not?’ in Pharma & Biotech
Revvity Signals offers AI solutions for R&D scientists and researchers. Learn how Signals One supports AI capabilities driving modern scientific discovery.
The Importance of FAIR Data and Processes
Data and Process Driven R&D Organizations Need to Transform
The Evolving Landscape of PROTAC® Technology: Implications for Small Molecule and Multimodal Drug Discovery
PROTAC technology and TPD research present many opportunities in drug discovery. Learn how Signals One provides a comprehensive R&D workflow.
Today's Lab Problem, Tomorrow's Solution: Integrating Benchtop Devices with Signals Digital Lab Exchange (DLX) powered by Scitara
Signals DLX can integrate any lab instrument or application with Signals Notebook. Learn how this provides more time for science, improves workflow and ends manual data entry.
Nexus 2021 Day One Recap: Cutting-Edge Solutions Redefining Research & Clinical Informatics
Nexus 2021 – Revvity Signals Virtual User Conference – kicked off today with an exciting schedule of keynotes, technology innovation spotlights, and industry case studies from companies including Merck, Janssen, Roche Diagnostics, Bayer, Gilead Science, Bristol Meyer Squibb, and more.
From Data Overload to Insight: Using AI and ML for Security Trend Prediction
Artificial intelligence (AI) and machine learning (ML) are revolutionizing the cybersecurity space. Learn how Revvity Signals uses AI and other techniques to protect data.
Why Cloud Matters in Scientific R&D
Revvity Signals handles all software development, allowing researchers to explore new drug therapies. Learn how our cloud-native software helps with performance, cost and scalability.
